Chimeric Antigen Receptor T Cells, the Shock of the New*

Abstract

Supported, in part, by Wake Forest Center for Hypertension and Cardiovascular Sciences pilot award for association of serum renin and outcomes in patients with septic shock. Dr. Khanna is also supported by a Wake Forest CTSI NIH/NCATS KL2 award for a pilot trial of hemodynamics and saturation monitoring on post-operative patients. Dr. Khanna's previous institution received grant funding for the Angiotensin II for the Treatment of High Output Shock 3 trial; he received funding from La Jolla Pharmaceuticals. REFERENCES 1. Maheshwari K, Nathanson BH, Munson SH, et al: The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients.